MyAverix Finance MyAverix Finance

HK

Innovative Pharmaceutical Biotech Ltd. (399)

Innovative Pharmaceutical Biotech Ltd. (399) is listed on HK. As of 2026-05-21, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 399

P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

Innovative Pharmaceutical Biotech Ltd. (399) — FAQ

What is 399's P/E ratio?

The price-to-earnings (P/E) ratio for Innovative Pharmaceutical Biotech Ltd. (399) is 18.00 (data as of 2026-05-21).

Does Innovative Pharmaceutical Biotech Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Innovative Pharmaceutical Biotech Ltd. (399). Check the MyAverix Finance app for the latest dividend data.

What exchange is 399 listed on?

399 is listed on HK.

What is Innovative Pharmaceutical Biotech Ltd.'s net margin?

Innovative Pharmaceutical Biotech Ltd. (399) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play